{{Rsnum
|rsid=11568388
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Chromosome=9
|Orientation=minus
|Gene=SLC28A3
|position=84290204
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=SLC28A3
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 0.0 | 100.0
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs11568388
|Name_s=SLC28A3: G367R
|Gene_s=SLC28A3
|Feature=Exon/NonSyn
|Evidence=PubMed ID:19940846
|Annotation=Reduced uptake of inosine and thymidine in oocytes
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA165111586
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}